Description
The global Hematology Instruments and Reagents market estimated at US$7.63 billion in the year 2021 is now projected to grow at a CAGR of 8.86% and reach US$12.69 billion by 2027.
The research report provides a comprehensive review of market trends (Technology, Product and Application analysis), market growth drivers, PEST Analysis (Political, Economic, Social and Technological Analysis) Market growth inhibitors, and strategic industry activities and SWOT Analysis of key players in the market. The report provides market estimates and forecast for geographic markets such as the North America (United States, Canada, Mexico and Rest of North America), South America (Brazil, Argentina Chile Colombia Peru Venezuela Ecuador and Rest of South America), Europe (Germany, France, U.K., Russia, Italy, Spain, Sweden, Netherlands, Poland, Austria, Belgium, Finland, Norway, Switzerland, Denmark, Czech Republic, Portugal and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Philippines, Malaysia and Rest of Asia-Pacific), Middle East (Iran, Turkey, Kuwait, UAE, Israel, Oman, Bahrain, Saudi Arabia, Qatar, Egypt and Rest of Middle East) & Africa.
North American hematology instruments and reagents market is expected to grow significantly over the forecast period. This growth can be attributed to the robust presence of major players and increasing investment to develop novel and higher accurate result generating medical devices. U.S. contributed around 78% of the total North American hematology instruments and reagents market and is estimated to have a market value of US$2.26 billion in the year 2021. Among the other noteworthy geographic markets are Canada and Mexico, each forecast to grow at 5.49% and 4.20% respectively over the 2021-2027 period.
Asia Pacific hematology instruments and reagents market is anticipated to witness an upsurge owing to the governments of these regions imposing favorable regulations and compliances for the consumption of advanced medical instrumentations in countries including China, Japan and India. China is expected to dominate the Asia-Pacific market and reach a market size of US$2.81 billion by 2027.
Within Europe, France, Germany, and the U.K. are the key countries responsible for the significant growth of the regional market. Germany is expected to grow at a fastest CAGR of 6.93% over the forecast period.
Meanwhile, the Middle East & Africa is expected to show limited growth due to the strong presence of under-developed countries in Africa who are still struggling to meet technology standards. However, any growth that the region experiences is expected to come from developing Middle Eastern nations such as Qatar, U.A.E, and Oman due to a similar growth pattern as the Asia Pacific.
Key players profiled in the report include Abbott Diagnostics; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Drucker Diagnostics; Horiba Ltd.; Instrumentation Laboratory Inc.; Merck KGaA; Roche Diagnostics AG; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Siemens Healthineers; Sysmex America Inc.; Sysmex Corporation and Tcoag Ireland Ltd., among others.
Research Methodology
Table of Contents
- Executive Summary
- Research Methodology
- Primary Research
- Secondary Research
- Market Analytics
- Revenue Forecasting
- Market Overview
- Market Definition
- Scope of the Study
- Research Objectives
- Assumptions & Limitations
- Market Structure
- Market Dynamics
- Introduction
- Microeconomic Factor Analysis
- Market Evolution
- Technology Roadmap
- Demand-Supply Dynamics
- Growth Drivers
- Restraints
- Opportunities
- Challenges
- Sustainable Strategies
- Market Trend Analysis (Product Analysis, Technology Analysis, Application Analysis)
- Industry Analysis
- Profitability analysis
- Supply Chain & Value Chain Analysis
- Porter’s Five Forces Analysis
- Bargaining power of Suppliers
- Bargaining Power of Buyers
- Threat of substitutes
- Threat of new entrants
- Degree of Competition
- PEST Analysis
- Upstream and downstream profitability analysis and opportunities
- COVID-19 impact analysis
- Russia-Ukraine crisis impact analysis
Global Hematology Instruments and Reagents Market Scope (Market size and projections, 2021-2027)
- Market analysis by product category
- Instruments
- Hematology analyzers
- Hematology flow cytometers
- Coagulation analyzers
- Others
- Reagents
- Coagulation reagents
- Flow cytometry reagents
- Immunohematology reagents
- Others
- Instruments
- Market analysis by hematologic disorder/disease
- Coagulation/hemostasis disorders
- Immune system disorders
- Heme synthesis disorders
- lymphocytic function
- Others
- Market analysis by application
- Testing and diagnosis
- Infectious disease testing
- Diseases and disorders diagnosis
- Others
- Market analysis by end user
- Research institutes
- Medical research
- Educational research
- Pharmaceutical research
- Diagnostic laboratories
- Hospitals and hospital laboratories
- Clinical laboratories
- Satellite laboratories
- Others
- Research institutes
- Emerging trends and technologies
- Multi technology & multi task hematology analyzers
- Hematology analyzer with 3D VCS technology
- Hematology analyzer with body fluid mode
- Blood clotting disorders
- Point-of-care (POC) testing
- POC coagulation analyzer technology
- Others
- Market analysis by region
- North America
- US
- Canada
- Mexico
- Others
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Peru
- Venezuela
- Ecuador
- Others
- Europe
- Germany
- France
- UK
- Russia
- Italy
- Spain
- Sweden
- Netherlands
- Poland
- Austria
- Belgium
- Finland
- Norway
- Switzerland
- Denmark
- Czech Republic
- Portugal
- Others
- Asia-Pacific
- China
- Japan
- South Korea
- Taiwan
- India
- Australia
- Indonesia
- Philippines
- Malaysia
- Others
- Middle East
- Iran
- Turkey
- Kuwait
- UAE
- Israel
- Oman
- Bahrain
- Saudi Arabia
- Qatar
- Egypt
- Others
- Africa
- Algeria
- Libya
- South Africa
- Sudan
- Zimbabwe
- Others
- North America
- Competitive Landscape
- Introduction
- Market share analysis by key market players (North America, South America, Europe, APAC, Africa)
- Market Strategy
- Mergers and Acquisitions
- New Product Launches
- Asset Transactions
- Financial Announcements
- Company Profile (key market players)
- Company profile 1
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 2
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 3
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 4
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 5
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 6
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 7
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 8
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 9
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Company profile 10
- Company Overview
- Strategic Initiatives
- Financial Analysis
- Product Benchmarking
- SWOT Analysis
- Other Companies
- Company profile 1
-
-
- 100+
-
